These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 7442949)

  • 1. Pharmacological and biochemical properties of BRL 14342, a novel potential antidepressant drug.
    Clark MS; Johnson AM; McClelland GR; Nelson DR
    Neuropharmacology; 1980 Dec; 19(12):1207-8. PubMed ID: 7442949
    [No Abstract]   [Full Text] [Related]  

  • 2. Action of the antidepressant pridefine (AHR-1118) on biogenic amines in the rat brain.
    Vosmer G; DeMet EM; Halaris AE
    Biochem Pharmacol; 1980 Oct; 29(19):2557-62. PubMed ID: 7426062
    [No Abstract]   [Full Text] [Related]  

  • 3. Chronic administration of the antidepressant-antipanic drug phenelzine and its N-acetylated analogue: effects on monoamine oxidase, biogenic amines, and alpha 2-adrenoreceptor function.
    McKenna KF; Baker GB; Coutts RT; Greenshaw AJ
    J Pharm Sci; 1992 Aug; 81(8):832-5. PubMed ID: 1383493
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Histochemical fluorescence detection of changes in central monoamine neurones provoked by drugs acting on the CNS.
    Fuxe K; Hökfelt T
    Triangle; 1971; 10(3):73-84. PubMed ID: 5138525
    [No Abstract]   [Full Text] [Related]  

  • 5. Biochemical and pharmacological evaluation of the novel antidepressant and serotonin uptake inhibitor 2-(3,4-Dichlorobenzyl)-2-dimethylamino-1-propanol hydrochloride.
    Gouret CJ; Porsolt R; Wettstein JG; Puech A; Soulard C; Pascaud X; Junien JL
    Arzneimittelforschung; 1990 Jun; 40(6):633-40. PubMed ID: 2168703
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mechanisms of action of antidepressant drugs.
    Hamon M
    Adv Biosci; 1978 Jul 24-25; 21():117-28. PubMed ID: 385392
    [No Abstract]   [Full Text] [Related]  

  • 7. The GABA hypothesis of depression and antidepressant drug action.
    Bartholini G; Lloyd KG; Scatton B; Zivkovic B; Morselli PL
    Psychopharmacol Bull; 1985; 21(3):385-8. PubMed ID: 2994153
    [No Abstract]   [Full Text] [Related]  

  • 8. Effects of the optical isomers of the narcotic antagonist analgesic pentazocine on brain and heart biogenic amines.
    Berkowitz BA
    Eur J Pharmacol; 1974 May; 26(2):359-65. PubMed ID: 4152866
    [No Abstract]   [Full Text] [Related]  

  • 9. The influence of quipazine on the turnover rate of serotonin.
    Grabowska M; Antkiewicz L; Michaluk J
    Biochem Pharmacol; 1974 Nov; 23(22):3211-2. PubMed ID: 4441411
    [No Abstract]   [Full Text] [Related]  

  • 10. Monoamine oxidase inhibition and brain amine metabolism after oral treatment with toloxatone in the rat.
    Keane PE; Kan JP; Sontag N; Benedetti MS
    J Pharm Pharmacol; 1979 Nov; 31(11):752-4. PubMed ID: 41906
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Responses of developing rats to L-tryptophan plus an maoi-II. Effects of repeated electroconvulsive shock.
    Atterwill CK; Green AR
    Neuropharmacology; 1980 Apr; 19(4):337-41. PubMed ID: 7189832
    [No Abstract]   [Full Text] [Related]  

  • 12. Use of monoamine oxidase inhibitors in chronic neurodegeneration.
    Riederer P; Müller T
    Expert Opin Drug Metab Toxicol; 2017 Feb; 13(2):233-240. PubMed ID: 27998194
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Content, release and absorption of biogenic amines in CNS structures of the rat under the influence of sultones (proceedings)].
    Christl A; Fischer HD; Franz E; Funk K; Keller G; Rudolph E; Ruhnke M
    Pharmazie; 1979; 34(5-6):300-1. PubMed ID: 515127
    [No Abstract]   [Full Text] [Related]  

  • 14. Actions of atropine, hemicholinium-3, and physostigmine on chlorpromazine-induced changes in rat brain monoamines.
    Bhatnagar SP
    Can J Physiol Pharmacol; 1974 Jun; 52(3):500-7. PubMed ID: 4152758
    [No Abstract]   [Full Text] [Related]  

  • 15. Effects of a new oxazolidinone derivative AS-8 on serotonin metabolism in the brains of mouse, rat and chick.
    Chilmonczyk Z
    Pol J Pharmacol; 1995; 47(5):445-9. PubMed ID: 8868138
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Monoamines and endogenous depression. Biochemical and pharmacological aspects].
    Scuvée-Moreau J; Dresse A
    Rev Med Liege; 1982 Jan; 37(1):1-7. PubMed ID: 7054862
    [No Abstract]   [Full Text] [Related]  

  • 17. Biogenic amine hypotheses of affective disorders.
    Garver DL; Davis JM
    Life Sci; 1979 Jan; 24(5):383-94. PubMed ID: 372718
    [No Abstract]   [Full Text] [Related]  

  • 18. Pharmacologic mechanisms of action of antidepressants.
    Frazer A; Conway P
    Psychiatr Clin North Am; 1984 Sep; 7(3):575-86. PubMed ID: 6091070
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of a new, short-acting and specific inhibitor of type A monoamine oxidase.
    Waldmeier PC; Baumann PA; Delini-Stula A; Bernasconi R; Sigg K; Buech O; Felner AE
    Mod Probl Pharmacopsychiatry; 1983; 19():31-52. PubMed ID: 6191211
    [No Abstract]   [Full Text] [Related]  

  • 20. The effects of perturbation of cerebral amine metabolism on operationally defined learning and memory processes of goldfish.
    Stahl SM; Narotzky RA; Boshes B; Zeller EA
    Biol Psychiatry; 1974 Dec; 9(3):295-323. PubMed ID: 4441577
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.